Highlights

04-02 Boston Scientific's 2026 Guidance 'Reasonable', RBC Says MT
04-01 Australia's Therapeutic Goods Administration says Boston Scientific conducting product correction for Accolade and Visionist pacemakers RE
03-31 Boston Scientific Corporation completed the acquisition of Valencia Technologies Corporation. CI
03-30 Top Midday Stories: Trump Touts Talks With New Iranian Regime, Renews Threats; Sysco to Acquire Jetro for $29.1 Billion MT
03-30 Boston Scientific Corporation Receives FDA Clearance for the Asurys Fluid Management System CI
03-30 Boston Scientific receives FDA clearance for the Asurys(TM) fluid management system RE
03-28 Boston Scientific Corporation Demonstrates Ekos Endovascular System Is Superior to Standard of Care for Treatment of Acute Pulmonary Embolism CI
03-28 Champion-Af Study of the Watchman Flx? Left Atrial Appendage Closure Device as A First-Line Therapy for Stroke Risk Reduction Meets All Primary and Secondary Safety and Efficacy Endpoints CI
02-26 Penumbra Seen as 'Strategic and Financial Fit' for Boston Scientific, RBC Says MT
02-23 Boston Scientific Expands Share Buyback by $4 Billion, Adds Two Directors MT
02-17 Health Care Down as Deal Activity Offsets Mixed Earnings -- Health Care Roundup DJ
02-17 Tranche Update on Boston Scientific Corporation's Equity Buyback Plan announced on December 14, 2020. CI
02-06 Markets Ask the Obvious Question Zonebourse
02-05 Boston Scientific Share Performance Hinges on CHAMPION-AF Clinical Trial Results, RBC Says MT
02-04 Nasdaq, S&P 500 Fall as Tech Sell-Off Continues MT
02-04 Boston Scientific shares fall as key segment's performance spooks investors RE
02-04 Top Midday Stories: Lilly Shares Soar After Strong Q4 Earnings, Guidance; Uber Q4 EPS Misses Target, CFO Stepping Down MT
02-04 Boston Scientific, AbbVie Beat Quarterly Views; Shares Slump Amid Weakness in Certain Segments MT
02-04 Boston Scientific Plunges on Disappointing 1Q Outlook Despite 4Q Earnings Beat DJ
02-04 Boston Scientific shares slide on cautious 2026 revenue forecast RE
02-04 Boston Scientific Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
02-04 Boston Scientific shares fall as key segment's performance spooks investors RE
02-04 Stocks Rise Pre-Bell Following End of Partial Government Shutdown; Alphabet Earnings on Deck MT
02-04 Boston Scientific Corporation Provides Earnings Guidance for the First Quarter and Full Year 2026 CI
02-04 Boston Scientific Sees More Growth after Earnings, Sales Rise DJ
No results for this search